Moldova vs Singapore: The number of people with susceptibility test result for rifampicin
Moldova
991
in 2021
Singapore
1,051
in 2021
Moldova rank
67th
Singapore rank
65th
The number of people with susceptibility test result for rifampicin over time
- Moldova
- Singapore
How they compare
Singapore currently reports 1,051 against 991 in Moldova, a difference of 60.
That makes Singapore's figure about 1.1 times Moldova's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Moldova ahead.
Moldova ranks 67th and Singapore ranks 65th of 155 countries.
Across the 2 decades both report, Moldova averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Moldova | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,394 | 1,090 | 304 | Moldova |
| 2020s | 915.5 | 1,058 | 143 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Moldova or Singapore?
- Singapore, at 1,051 against 991 in Moldova as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Moldova and Singapore?
- 60, with Singapore ahead.
- How many years of comparable data are there for Moldova and Singapore?
- 5 years are reported by both, from 2017 to 2021.
- How do Moldova and Singapore rank globally for the number of people with susceptibility test result for rifampicin?
- Moldova ranks 67th and Singapore ranks 65th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.